HealthLynked Q3: Cash Falls to $16,594, Going Concern Doubt Persists
HLYK sits 15% above its 52-week low of $0.738 on elevated volume (5.5× avg).
Summary
HealthLynked posted a $3.3 million nine-month loss and held only $16,594 of cash at quarter end, while reiterating substantial doubt about its ability to continue as a going concern without new funding.
Key Events · Earnings and Guidance · HLYK
-
Cash Nearly Depleted at Quarter End
Cash stood at $16,594 on September 30, 2026, down from $37,136 at December 31, 2025, against a working capital deficit of $1,416,099.
-
Nine-Month Loss Widens 28%
The net loss was $3,329,901 versus $2,603,777 a year earlier, on revenue that fell 53% to $829,229 from $1,755,113.
-
Going Concern Doubt Reiterated
Management concluded that without additional funding the company will not have sufficient funds to meet obligations through November 16, 2027.
-
CEO Debt Refinanced Into Secured Note
Dr. Dent's prior notes, advances and deferred pay were consolidated into a $5,715,812 secured note at 12% maturing February 2, 2029, carried at a $6,696,618 fair value; the conversion price was cut to $2.75.
Analysis · HLYK · Industrial Applications And Services
Cash of just $16,594 at September 30, 2026, against a $1,416,099 working capital deficit is the headline, and management states plainly that without additional funding the company cannot meet obligations through November 16, 2027. Operations are consuming cash faster than the shrinking business generates it: the nine-month net loss widened 28% to $3,329,901 on revenue that fell 53% to $829,229. Survival is being financed by insider and third-party debt. CEO Michael Dent refinanced roughly $5.7 million of his own notes and advances into a single secured note at 12%, now carried at a $6,696,618 fair value, and the company issued a string of small convertible notes in the quarter and after. A $7,500,000 S-1 equity offering filed in February 2026 remains unsold and subject to market demand. Note that the reported $2,429,867 loss on change in fair value of debt is a non-cash mark-to-market entry, not a cash outflow, though it inflates the reported net loss. With the stock at $0.85 and essentially no cash, the next capital raise is the only thing standing between the company and insolvency.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HLYK was trading at $0.85 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $2.5M. The 52-week trading range was $0.74 to $6.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.